All filters
Meeting
INTEREST 2022
Slidesets
COVID-19 Associated Mucormycosis - K. Marr, MD, MBA
Presented at:
COVID-19 Clinical Forum 2021
Slidesets
Update on COVID-19 Therapeutics - D. Kuritzkes, MD (July Edition)
Presented at:
COVID-19 Clinical Forum 2021
Slidesets
Anticoagulation in COVID-19 - O. Berwanger, MD, PhD
Presented at:
COVID-19 Clinical Forum 2021
Abstracts
Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of-Care in the ODYSSEY Trial
C. Kityo
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Early Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African Countries
E. Rabold
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Pediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020
D. Carpenter
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Efficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic Review
L. Evitt
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial
A. Compagnucci
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
B/F/Taf in Virologically Suppressed Adolescents and Children: Two-Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers
E. Natukunda
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Long-term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen in in Children and Adolescents Living with HIV
S. Anugulruengkitt
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Pharmacokinetics and Safety of Dispersible- and Immediate-Release FDC Dolutegravir/Abacavir/Lamivudine in Children with HIV Weighing ≥14 kg: Preliminary Results from IMPAACT 2019
K. Brooks
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Pharmacokinetics, Safety and Acceptability of a Single Dose of Abacavir/Lamivudine/Lopinavir/Ritonavir (4-In-1) Fixed-Dose Granule Formulation In Neonates: PETITE Study
T. Cressey
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Clinical Impact and Cost-Effectiveness of Viral Load Testing (VLT) to Inform the Transition to Pediatric Dolutegravir (DTG) in Antiretroviral Therapy (ART)-Experienced Children With HIV in South Africa
R. Brenner
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Weight Gain in Children and Adolescents on Dolutegravir vs Standard-of-Care in the ODYSSEY Trial
H. Mujuru
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Dolutegravir and Weight Gain to Adolescents Living with HIV at Baylor Mwanza-Tanzania
E. Masunga
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Longitudinal Study on Insulin Resistance and Metabolic Syndrome in Children with Perinatal HIV Infection and HIV Exposed Uninfected Children in South Africa
C. Davies
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Hypertensive Disorders in Pregnancy and HIV: A Province-Wide Cohort Analysis During 2018 and 2019 in the Western Cape, South Africa
A. Slogrove
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Bone Mineral Density/Content of Postpartum Mothers Taking Treatment Including DTG Vs EFV, TDF Vs TAF in Pregnancy and Their Infants: Randomized IMPAACT 2010 Trial
T. Mbengeranwa
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Impact of the COVID-19 pandemic on perinatal HIV prevention In Canada: Canadian Perinatal HIV Surveillance Program
J. Singer
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
A Comparative Multi-Country Analysis of the Impact of COVID-19 on HIV Services for Pregnant and Breastfeeding Women and Their Infants
A. Vrazo
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
The Impact of COVID-19 on HIV Services for Children Living with HIV Across 14 Countries
A. Amzel
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
Knowledge and Perceptions of Covid-19 Among Young People Living With HIV in Malawi and the Impact of the Pandemic on Their Health and Wellbeing
K. Hirani
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021
Abstracts
More Frequent Viral Load Testing, With Point-Of-Care Tests Has No Impact on Viral Suppression in Postpartum HIV-Positive Women in a Randomized Controlled Trial in 2 Clinics in Johannesburg, South Africa
L. Fairlie
Reviews in Antiviral Therapy & Infectious Diseases 5, 2021
Presented at:
International Workshop on HIV Pediatrics 2021